1,7-phenanthroline has been researched along with Cerebral Malaria in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Olivier, M; Richer, MJ; Smith, LK; Van Den Ham, KM | 1 |
1 other study(ies) available for 1,7-phenanthroline and Cerebral Malaria
Article | Year |
---|---|
Protein Tyrosine Phosphatase Inhibition Prevents Experimental Cerebral Malaria by Precluding CXCR3 Expression on T Cells.
Topics: Animals; Brain; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Interleukin-10; Liver; Malaria, Cerebral; Mice, Inbred C57BL; Mice, Knockout; Organometallic Compounds; Phenanthrolines; Plasmodium berghei; Protein Tyrosine Phosphatases; Receptors, Antigen, T-Cell; Receptors, CXCR3; Signal Transduction; Spleen; T-Lymphocytes; Up-Regulation | 2017 |